LifePulse™ Corporation

Animal Health, In Clinical Use Today

Since March 2022, hundreds of dogs, cats, and horses have been treated with the VetPulse 2000 for dozens of indications.

Indications

Soft tissue sarcoma

Squamous cell carcinoma

Epulis

Mast cell tumors

Melanoma

Osteosarcoma

Feline injection site sarcoma

Localized cutaneous lymphoma

Perianal / rectal tumors

Vaginal tumors

Mammary tumors

Some internal tumors

Adenocarcinoma

Delivery of immunotherapy and vaccines

Clinical evidence gallery

Day 0

Day 7

Oral Melanoma

Day 0 → Day 7 following IntelliPulse™ treatment.

Day 0

Day 14

Oral Squamous Cell Carcinoma

Day 0 → Day 14 following IntelliPulse™ treatment.

Distribution

Reaching practices nationwide with Patterson Veterinary

The Patterson Veterinary partnership puts the VetPulse 2000 within reach of practices across the United States, backed by devices already in clinical use.

Q3 2026

Patterson launch

Nationwide availability through Patterson Veterinary begins.

Nationwide

Coverage

Practices served across the United States.

In clinic

Live installations

Devices already treating patients in US veterinary centers.